Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings.

Navari S, Dazzan P.

Psychol Med. 2009 Nov;39(11):1763-77. doi: 10.1017/S0033291709005315. Epub 2009 Apr 2. Review.

PMID:
19338710
2.

The effects of antipsychotics on brain structure: what have we learnt from structural imaging of schizophrenia?

Borgwardt SJ, Smieskova R, Fusar-Poli P, Bendfeldt K, Riecher-Rössler A.

Psychol Med. 2009 Nov;39(11):1781-2. doi: 10.1017/S0033291709006060. Epub 2009 May 29. No abstract available.

PMID:
19476691
3.

Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study.

Dazzan P, Morgan KD, Orr K, Hutchinson G, Chitnis X, Suckling J, Fearon P, McGuire PK, Mallett RM, Jones PB, Leff J, Murray RM.

Neuropsychopharmacology. 2005 Apr;30(4):765-74.

4.

Brain volume changes in schizophrenia: how do they arise? What do they mean?

Lewis DA.

Psychol Med. 2009 Nov;39(11):1779-80. doi: 10.1017/S003329170900573X. Epub 2009 Apr 20. No abstract available.

PMID:
19379533
5.

[Changes in brain structure caused by neuroleptic medication].

Scherk H, Falkai P.

Nervenarzt. 2004 Nov;75(11):1112-7. Review. German.

PMID:
15365632
6.

Effects of antipsychotics on brain structure.

Scherk H, Falkai P.

Curr Opin Psychiatry. 2006 Mar;19(2):145-50. Review.

PMID:
16612194
7.
8.

The effects of antipsychotics on the brain: what have we learnt from structural imaging of schizophrenia?--a systematic review.

Smieskova R, Fusar-Poli P, Allen P, Bendfeldt K, Stieglitz RD, Drewe J, Radue EW, McGuire PK, Riecher-Rössler A, Borgwardt SJ.

Curr Pharm Des. 2009;15(22):2535-49. Review.

PMID:
19689326
9.

Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.

Velakoulis D, Wood SJ, Wong MT, McGorry PD, Yung A, Phillips L, Smith D, Brewer W, Proffitt T, Desmond P, Pantelis C.

Arch Gen Psychiatry. 2006 Feb;63(2):139-49.

PMID:
16461856
10.

Regional change in brain morphometry in schizophrenia associated with antipsychotic treatment.

McClure RK, Phillips I, Jazayerli R, Barnett A, Coppola R, Weinberger DR.

Psychiatry Res. 2006 Dec 1;148(2-3):121-32. Epub 2006 Nov 9.

PMID:
17097276
11.

A systematic review of the effects of antipsychotic drugs on brain volume.

Moncrieff J, Leo J.

Psychol Med. 2010 Sep;40(9):1409-22. doi: 10.1017/S0033291709992297. Epub 2010 Jan 20. Review.

PMID:
20085668
12.

Comparison of progressive cortical gray matter loss in childhood-onset schizophrenia with that in childhood-onset atypical psychoses.

Gogtay N, Sporn A, Clasen LS, Nugent TF 3rd, Greenstein D, Nicolson R, Giedd JN, Lenane M, Gochman P, Evans A, Rapoport JL.

Arch Gen Psychiatry. 2004 Jan;61(1):17-22.

PMID:
14706940
13.

Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia.

Ho BC, Andreasen NC, Ziebell S, Pierson R, Magnotta V.

Arch Gen Psychiatry. 2011 Feb;68(2):128-37. doi: 10.1001/archgenpsychiatry.2010.199.

14.

Structural neuroimaging of the basal ganglia in schizophrenic patients: a review.

Brandt GN, Bonelli RM.

Wien Med Wochenschr. 2008;158(3-4):84-90. doi: 10.1007/s10354-007-0478-7. Review.

PMID:
18330524
15.

Basal ganglia volumes in drug-naive first-episode schizophrenia patients before and after short-term treatment with either a typical or an atypical antipsychotic drug.

Glenthoj A, Glenthoj BY, Mackeprang T, Pagsberg AK, Hemmingsen RP, Jernigan TL, Baaré WF.

Psychiatry Res. 2007 Apr 15;154(3):199-208. Epub 2007 Mar 13.

PMID:
17360162
16.

Progressive loss of cortical gray matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studies.

Vita A, De Peri L, Deste G, Sacchetti E.

Transl Psychiatry. 2012 Nov 20;2:e190. doi: 10.1038/tp.2012.116. Review. Erratum in: Transl Psychiatry. 2013;3:e275.

17.

Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies.

Fusar-Poli P, Smieskova R, Kempton MJ, Ho BC, Andreasen NC, Borgwardt S.

Neurosci Biobehav Rev. 2013 Sep;37(8):1680-91. doi: 10.1016/j.neubiorev.2013.06.001. Epub 2013 Jun 14.

18.

Brain pathology in first-episode psychosis: magnetization transfer imaging provides additional information to MRI measurements of volume loss.

Price G, Cercignani M, Chu EM, Barnes TR, Barker GJ, Joyce EM, Ron MA.

Neuroimage. 2010 Jan 1;49(1):185-92. doi: 10.1016/j.neuroimage.2009.07.037. Epub 2009 Jul 23.

19.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

20.

Early striatal hypertrophy in first-episode psychosis within 3 weeks of initiating antipsychotic drug treatment.

Chua SE, Deng Y, Chen EY, Law CW, Chiu CP, Cheung C, Wong JC, Lienenkaëmper N, Cheung V, Suckling J, McAlonan GM.

Psychol Med. 2009 May;39(5):793-800. doi: 10.1017/S0033291708004212. Epub 2008 Aug 20.

PMID:
18713487

Supplemental Content

Support Center